AEHR Aehr Test Systems

$AEHR Aehr Test Systems (AEHR) recent share-price decline appears overdone and creates a "buying opportunity," Oppenheimer said in a report Wednesday, after meeting with management at the CEO Summit. I’ve been buying these low prices. Should rebound soon.

$AEHR hilarious overreaction. If you were short congrats, if you’re short still, you’re playing with fire.

$AEHR buying more here. Just a matter of time before this turns around and surges back over $100

$AEHR absolutely hilarious that to fight AI disinformation about late earnings they felt the need to put out a release date so early and once again note the one month fiscal shift That, or they are just incredibly excited

$AEHR I got an answer from Investor Relations regarding ER. The change in fiscal year explain the change in reporting. All is well! “Hi. Aehr's Q127 report date will likely be Monday, November 2nd. A confirmed date with conference call info will be announced in a press release typically issued about a week or more in advance. Aehr moved their fiscal year forward a month to align more closely with reporting periods of customers and semi test peers (as noted on their FY26 Q3 call this past April). The current fiscal 2027 year began June 27, 2026 and will end June 25, 2027. So Q127 is now reported in early Nov. Q2 will likely be reported during the first week in February, and so forth.” Jim Byers | Senior Vice President PondelWilkinson Inc. Investor Relations | Strategic Public Relations M: 415-309-2079 mailto:jbyers@pondel.com

$AEHR am i to understand that because google/the AIs predicted earnings would be now - merely observing prior year releases and ingoring the fiscal year change that means the quarter ended in Sept - that people are absolutely slaughtering themselves? Earnings will be in November

$AEHR 11:36 AM EDT, 10/14/2026 (MT Newswires) -- Aehr Test Systems (AEHR) recent share-price decline following Teradyne's (TER) Titan HP announcement appears overdone and creates a "buying opportunity," Oppenheimer said in a report Wednesday, after meeting with management at the CEO Summit. Oppenheimer also sees longer-term opportunity from "broader hyperscaler adoption" and higher-value FOX configurations, while a second major AI processor remains a "key catalyst." However, it said meaningful high-volume manufacturing adoption could be "gradual" because the system still needs pilot-production validation in Taiwan, according to the report. Oppenheimer maintained its estimates, outperform rating and $120 price target, on Aehr Test Systems.

$AEHR This morning Aehr Test announced $6M in follow-on orders for Sonoma burn-in systems supporting a next-generation AI processor, with deployment tied to an expected 2027 production ramp.

$AEHR Tomorrow 110$ again without the earnings announcement. If they will announce earnings it will fly...!!!💰💰💰

$AEHR this has now had ~6 months of pretty volatile price 'consolidation' during which they have added to and expanded dramatically within their AI customer base. The failure rates of current AI servers are so high that testing chips at the package and wafer levels is an incredibly high ROI investment that is clearly being made - the 'bottleneck' to adoption has been customers finding floor space at the fab/OSAT and integrating a new process into the production line. The July guide of ~$140M in revenue, exceeding what had been ~$70M in expected revenue, indicates this process issue is being rapidly resolved - and once engrained in the process, it is just as difficult to be removed. SPCX is now also public and is talking so much about a data center in space - even raising $40B of debt on the premise - that it will presumably need to at least attempt something. Anything sent to space has be tested at the wafer level - this is essentially by definition. So it obviously becomes a customer

$AEHR crossover on the MACD on the 6 month 4 hour. We should see a nice move pretty soon. My guess is 108-110 in the coming weeks.

$AEHR So… We know they changed fiscal year reporting. We know the ER dates- Nov 2 We know they are continuing to generate revenue - $6 mil follow up order We know last quarter they beat EPS and revenue We know management Gave very strong guidance for FY 2027. $130-150m We DON’T know this quarter’s numbers yet. But we do know analysts are forecasting EPS of .09 to .10 and revenue of $26.6 to 26.8 mil IF they report .11 to .12 and revenue of $27 -29 mil and maintain the guidance WE KNOW this is going to pop!

$AEHR Weak hands are just throwing in the towel, but I doubled my position at $97! 📈💸🚀 #investing #stocks #opportunity

$AEHR Insiders were too busy dumping their shares to remember they had an earnings report coming up.

$AEHR sold off from Fridays breakout zone but, intraday it did bounce and closed above the 9ema which is bullish for me. Will watch for a $100 break in market strength.

$AEHR i’ve only already followed this stock for about 6 to 8 months but I do know it goes up 50% and down 50% As much as a different stocks go up and down 5% so I’m not too worried yet I’m still 8% ha ha ha ha I don’t know how much longer though

$AEHR just don’t trust this management team anymore and their ability to execute. Hope I am wrong for the longs but the lack of news is deafening.

$AEHR insiders seem to have been selling shares repeatedly into major rallies. What's concerning is that we've seen substantial insider selling but essentially no open-market insider buying over the past year. Not proof of anything improper, but definitely a pattern worth watching.

$AEHR $AEHR earnings were NOT delayed. The Board approved a fiscal year-end change back in April, moving it from late May to late June. As a result, Q1 FY27 only ended on Sept. 25. Earnings should now be expected in early November. Calendars showing Oct. 6 were based on the old schedule.

$AEHR Aehr moved their fiscal year to start one month later meaning earnings will be in early November. I know most places list an incorrect date. Aehr will announce the earnings date about a week ahead. Their website will have it listed when they do.